Published in J Affect Disord on January 01, 2004
The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys. Epidemiol Psichiatr Soc (2009) 3.55
Posttraumatic stress disorder in survivors of acute lung injury: evaluating the Impact of Event Scale-Revised. Chest (2013) 3.00
Prevalence and Axis I comorbidity of full and partial posttraumatic stress disorder in the United States: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions. J Anxiety Disord (2010) 2.05
Trauma and posttraumatic stress symptoms predict alcohol and other drug consequence trajectories in the first year of college. J Consult Clin Psychol (2012) 1.38
Women reporting intimate partner violence in India: associations with PTSD and depressive symptoms. Arch Womens Ment Health (2009) 1.15
Learning to obtain reward, but not avoid punishment, is affected by presence of PTSD symptoms in male veterans: empirical data and computational model. PLoS One (2013) 0.99
Posttraumatic stress disorder and not depression is associated with shorter leukocyte telomere length: findings from 3,000 participants in the population-based KORA F4 study. PLoS One (2013) 0.98
Subthreshold posttraumatic stress disorder in the world health organization world mental health surveys. Biol Psychiatry (2014) 0.96
Influence of PTSD symptom clusters on smoking status among help-seeking Iraq and Afghanistan veterans. Nicotine Tob Res (2009) 0.92
PTSD in Vietnamese Americans following Hurricane Katrina: prevalence, patterns, and predictors. J Trauma Stress (2009) 0.92
Posttraumatic Stress Disorder and Substance Use Disorders in College Students. J College Stud Psychother (2008) 0.90
Personality disorders associated with full and partial posttraumatic stress disorder in the U.S. population: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions. J Psychiatr Res (2010) 0.90
The WHO World Mental Health (WMH) Surveys. Psychiatrie (Stuttg) (2009) 0.88
Coping, PTSD symptoms, and alcohol involvement in trauma-exposed college students in the first three years of college. Psychol Addict Behav (2014) 0.86
Interleukin-6 and soluble interleukin-6 receptor levels in posttraumatic stress disorder: associations with lifetime diagnostic status and psychological context. Biol Psychol (2014) 0.83
Depression and post-traumatic stress disorder after aneurysmal subarachnoid haemorrhage in relation to lifetime psychiatric morbidity. Br J Neurosurg (2011) 0.82
Alcohol craving and demand mediate the relation between posttraumatic stress symptoms and alcohol-related consequences. Exp Clin Psychopharmacol (2015) 0.81
Posttraumatic stress disorder and symptoms among American Indians and Alaska Natives: a review of the literature. Soc Psychiatry Psychiatr Epidemiol (2014) 0.80
PTSD symptom severity is associated with increased recruitment of top-down attentional control in a trauma-exposed sample. Neuroimage Clin (2014) 0.78
Transition and change: prospective effects of posttraumatic stress on smoking trajectories in the first year of college. Health Psychol (2012) 0.78
Mindfulness-Oriented Recovery Enhancement versus CBT for co-occurring substance dependence, traumatic stress, and psychiatric disorders: Proximal outcomes from a pragmatic randomized trial. Behav Res Ther (2015) 0.78
Posttraumatic stress symptoms and tobacco abstinence effects in a non-clinical sample: evaluating the mediating role of negative affect reduction smoking expectancies. J Psychopharmacol (2014) 0.77
Posttraumatic stress disorders and extent of psychosocial impairments five years after a traffic accident. Psychosoc Med (2005) 0.77
Mitochondrial genetic variants identified to be associated with posttraumatic stress disorder. Transl Psychiatry (2015) 0.77
Post-traumatic stress disorder symptoms, underlying affective vulnerabilities, and smoking for affect regulation. Am J Addict (2015) 0.76
Discrepancy in diagnosis and treatment of post-traumatic stress disorder (PTSD): treatment for the wrong reason. J Behav Health Serv Res (2012) 0.76
Rates of Subthreshold PTSD Among U.S. Military Veterans and Service Members: A Literature Review. Mil Psychol (2016) 0.75
Preliminary Study of Acute Changes in Emotion Processing in Trauma Survivors with PTSD Symptoms. PLoS One (2016) 0.75
Exposure-Based CBT for Older Adults After Fall Injury: Description of a Manualized, Time-Limited Intervention for Anxiety. Cogn Behav Pract (2014) 0.75
Differential treatment response trajectories in individuals with subclinical and clinical PTSD. J Anxiety Disord (2016) 0.75
Specificity of cognitive and behavioral complaints in post-traumatic stress disorder and mild traumatic brain injury. Behav Sci (Basel) (2015) 0.75
Post-traumatic stress disorder symptom burden and gender each affect generalization in a reward- and punishment-learning task. PLoS One (2017) 0.75
Beyond symptom self-report: use of a computer "avatar" to assess post-traumatic stress disorder (PTSD) symptoms. Stress (2016) 0.75
Post-traumatic stress disorder among people exposed to the Ventotene street disaster in Rome. Clin Pract Epidemiol Ment Health (2008) 0.75
Objective neuropsychological deficits in post-traumatic stress disorder and mild traumatic brain injury: what remains beyond symptom similarity? Behav Sci (Basel) (2014) 0.75
Examining PTSD treatment choice among individuals with subthreshold PTSD. Behav Res Ther (2015) 0.75
Post-traumatic stress disorder in parturients delivering by caesarean section and the implication of anaesthesia: a prospective cohort study. Health Qual Life Outcomes (2017) 0.75
Anatomy of the anterolateral ligament of the knee. J Anat (2013) 3.68
Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry (2005) 3.00
So depression is an inflammatory disease, but where does the inflammation come from? BMC Med (2013) 2.02
Relation of levels of serum lipoproteins to depression after acute myocardial infarction. Am J Cardiol (2002) 1.92
Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol (2002) 1.67
Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. J Clin Psychopharmacol (2002) 1.66
The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. Int J Neuropsychopharmacol (2002) 1.60
Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev (2011) 1.58
Activation of the inflammatory response system in autism. Neuropsychobiology (2002) 1.56
Diagnosis of myalgic encephalomyelitis: where are we now? Expert Opin Med Diagn (2013) 1.43
Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus. J Affect Disord (2002) 1.30
Stability of interleukin 6, soluble interleukin 6 receptor, interleukin 10 and CC16 in human serum. Cytokine (2002) 1.27
The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression. J Psychiatry Neurosci (2004) 1.24
Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway. Mol Neurobiol (2013) 1.23
Inflammatory markers in depressed post-myocardial infarction patients. J Psychiatr Res (2005) 1.13
In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry (2010) 1.06
Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol. J Psychosom Res (2007) 1.04
A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome. Metab Brain Dis (2012) 1.04
Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness. BMC Med (2013) 1.03
Baseline immune activation as a risk factor for the onset of depression during interferon-alpha treatment. Biol Psychiatry (2006) 1.02
Stimulatory effect of antidepressants on the production of IL-6. Int Immunopharmacol (2004) 1.01
Depression, traumatic stress and interleukin-6. J Affect Disord (2010) 1.01
Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor alpha and interleukin-6. Psychiatry Res (2005) 1.00
Toxic rise of clozapine plasma concentrations in relation to inflammation. Eur Neuropsychopharmacol (2003) 1.00
Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses. BMC Med (2015) 0.97
Putative neuroprotective agents in neuropsychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.96
Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.96
Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.94
A review on cognitive behavorial therapy (CBT) and graded exercise therapy (GET) in myalgic encephalomyelitis (ME) / chronic fatigue syndrome (CFS): CBT/GET is not only ineffective and not evidence-based, but also potentially harmful for many patients with ME/CFS. Neuro Endocrinol Lett (2009) 0.94
Selective adsorption and separation of xylene isomers and ethylbenzene with the microporous vanadium(IV) terephthalate MIL-47. Angew Chem Int Ed Engl (2007) 0.92
(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: from antioxidants to kinase inhibitors. Prog Neuropsychopharmacol Biol Psychiatry (2011) 0.92
Nutrient intakes and the common mental disorders in women. J Affect Disord (2012) 0.92
Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells. Neuro Endocrinol Lett (2007) 0.91
p-Xylene-selective metal-organic frameworks: a case of topology-directed selectivity. J Am Chem Soc (2011) 0.89
Activation of the inflammatory response system: A new look at the etiopathogenesis of major depression. Neuro Endocrinol Lett (1999) 0.88
Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications. Mol Neurobiol (2013) 0.88
Serological observations in patients suffering from acute manic episodes. Hum Psychopharmacol (2002) 0.87
Herpes viruses, cytokines, and altered hemostasis in vital exhaustion. Psychosom Med (2003) 0.87
The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder. J Affect Disord (2012) 0.87
Serum amino acids, biopterin and neopterin during long-term immunotherapy with interferon-alpha in high-risk melanoma patients. Psychiatry Res (2003) 0.86
Neurodegeneration in Parkinson's disease: interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins. Mol Neurobiol (2013) 0.86
Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications. CNS Drugs (2014) 0.86
Total antioxidant status correlates with cognitive impairment in patients with recurrent depressive disorder. Neurochem Res (2012) 0.85
Association between inducible and neuronal nitric oxide synthase polymorphisms and recurrent depressive disorder. J Affect Disord (2011) 0.85
Selective adsorption and separation of ortho-substituted alkylaromatics with the microporous aluminum terephthalate MIL-53. J Am Chem Soc (2008) 0.85
CO2 challenge results in hypothalamic-pituitary-adrenal activation in healthy volunteers. J Psychopharmacol (2005) 0.85
Serotonergic disturbances in autistic disorder: L-5-hydroxytryptophan administration to autistic youngsters increases the blood concentrations of serotonin in patients but not in controls. Life Sci (2005) 0.85
Biological underpinnings of the commonalities in depression, somatization, and Chronic Fatigue Syndrome. Med Hypotheses (2012) 0.85
Single-stage bilateral total hip arthroplasty in patients less than 35 years. Forty arthroplasties with 5-17 years follow-up. Acta Orthop Belg (2009) 0.84
Ebola virus: melatonin as a readily available treatment option. J Med Virol (2015) 0.84
CO2 challenge induced HPA axis activation in panic. Int J Neuropsychopharmacol (2006) 0.84
Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways. Metab Brain Dis (2013) 0.84
Lowered omega-3 PUFAs are related to major depression, but not to somatization syndrome. J Affect Disord (2009) 0.84
A new animal model of (chronic) depression induced by repeated and intermittent lipopolysaccharide administration for 4 months. Brain Behav Immun (2013) 0.84
Increased IL-6 trans-signaling in depression: focus on the tryptophan catabolite pathway, melatonin and neuroprogression. Pharmacol Rep (2013) 0.83
Inflammation-related disorders in the tryptophan catabolite pathway in depression and somatization. Adv Protein Chem Struct Biol (2012) 0.83
Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.82
Nitric oxide plasma concentration associated with cognitive impairment in patients with recurrent depressive disorder. Neurosci Lett (2012) 0.82
Age-dependent stimulatory effect of desipramine and fluoxetine pretreatment on metastasis formation by B16F10 melanoma in male C57BL/6 mice. Pharmacol Rep (2010) 0.82
Framework breathing in the vapour-phase adsorption and separation of xylene isomers with the metal-organic framework MIL-53. Chemistry (2009) 0.82
Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites. Curr Psychiatry Rep (2015) 0.82
Melatonin: an overlooked factor in schizophrenia and in the inhibition of anti-psychotic side effects. Metab Brain Dis (2012) 0.81
The glutathione system: a new drug target in neuroimmune disorders. Mol Neurobiol (2014) 0.81
Behavioral changes in rats after acute, chronic and repeated administration of interleukin-1beta: relevance for affective disorders. J Affect Disord (2003) 0.81
Biobutanol separation with the metal-organic framework ZIF-8. ChemSusChem (2011) 0.81
The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs). Mol Neurobiol (2013) 0.80
Increased nuclear factor-κB and loss of p53 are key mechanisms in Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS). Med Hypotheses (2012) 0.80
The effect of cocaine sensitization on mouse immunoreactivity. Eur J Pharmacol (2004) 0.80
Vascular endothelial growth factor receptor 2 gene (KDR) polymorphisms and expression levels in depressive disorder. J Affect Disord (2012) 0.80
Mitochondrial dysfunction in the pathophysiology of bipolar disorder: effects of pharmacotherapy. Mini Rev Med Chem (2015) 0.79
Oxidative stress and lowered total antioxidant status are associated with a history of suicide attempts. J Affect Disord (2013) 0.79
Psychobiological aspects of somatoform disorders: contributions of monoaminergic transmitter systems. Neuropsychobiology (2004) 0.79
Metal-organic frameworks as high-potential adsorbents for liquid-phase separations of olefins, alkylnaphthalenes and dichlorobenzenes. Phys Chem Chem Phys (2009) 0.79
Case definitions and diagnostic criteria for Myalgic Encephalomyelitis and Chronic fatigue Syndrome: from clinical-consensus to evidence-based case definitions. Neuro Endocrinol Lett (2013) 0.79
Malondialdehyde plasma concentration correlates with declarative and working memory in patients with recurrent depressive disorder. Mol Biol Rep (2011) 0.79
A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior. BMC Med (2013) 0.79
Vascular endothelial growth factor gene (VEGFA) polymorphisms may serve as prognostic factors for recurrent depressive disorder development. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.78
Postpartum depression: psychoneuroimmunological underpinnings and treatment. Neuropsychiatr Dis Treat (2013) 0.78
Serum testosterone concentration in male autistic youngsters. Neuro Endocrinol Lett (2010) 0.78
Variants of Base Excision Repair Genes MUTYH , PARP1 and XRCC1 in Alzheimer's Disease Risk. Neuropsychobiology (2015) 0.78
An inducible nitric oxide synthase polymorphism is associated with the risk of recurrent depressive disorder. Neurosci Lett (2010) 0.78
Manganese superoxide dismutase gene expression and cognitive functions in recurrent depressive disorder. Neuropsychobiology (2014) 0.78
Total hip arthroplasty in inflammatory arthritis in patients under 35 years. A 7 to 19 year follow-up. Hip Int (2010) 0.77
Inhibition of 2,4-dinitrofluorobenzene-induced contact hypersensitivity reaction by antidepressant drugs. Pharmacol Rep (2013) 0.77
Inhibitory effect of antidepressants on B16F10 melanoma tumor growth. Pharmacol Rep (2013) 0.77
Fatty acid profile and affective dysregulation in irritable bowel syndrome. Lipids (2004) 0.77
Increased mitogen-induced lymphocyte proliferation in treatment resistant depression: a preliminary study. Neuro Endocrinol Lett (2004) 0.77
Inhibitory effects of amantadine on the production of pro-inflammatory cytokines by stimulated in vitro human blood. Pharmacol Rep (2010) 0.77
Inhibitory effect of antidepressant drugs on contact hypersensitivity reaction. Pharmacol Rep (2012) 0.77
Gut Permeability and Microbiota in Parkinson's Disease: Role of Depression, Tryptophan Catabolites, Oxidative and Nitrosative Stress and Melatonergic Pathways. Curr Pharm Des (2016) 0.77
Polyunsaturated fatty acids: do they have a role in the pathophysiology of autism? Neuro Endocrinol Lett (2006) 0.77
How Immune-inflammatory processes link CNS and psychiatric disorders: Classification and Treatment Implications. CNS Neurol Disord Drug Targets (2016) 0.77
The Gut-Brain Axis, Including the Microbiome, Leaky Gut and Bacterial Translocation: Mechanisms and Pathophysiological Role in Alzheimer's Disease. Curr Pharm Des (2016) 0.76
Psychomotor, neuroendocrine and behavioural effects after oral administration of levodopa in normal volunteers. Psychiatry Res (2004) 0.76
Hypothalamic-pituitary-adrenal axis function following a 35% CO2 inhalation in healthy volunteers. Prog Neuropsychopharmacol Biol Psychiatry (2004) 0.76
Influence of antidepressants on intracellular levels of cyclic adenosine monophosphate in human peripheral blood mononuclear cells. Eur Neuropsychopharmacol (2003) 0.76
Stimulatory effect of antidepressant drug pretreatment on progression of B16F10 melanoma in high-active male and female C57BL/6J mice. J Neuroimmunol (2011) 0.76
High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance. World J Biol Psychiatry (2015) 0.76
Crosstalk between contact hypersensitivity reaction and antidepressant drugs. Pharmacol Rep (2013) 0.76